
688185 · CanSino Biologics, Inc. Class A
99.56
CNYUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Yuan16.04B
PE
557.20
EV/EBITDA
216.3
DIV Yield
0%
Payout Ratio
0%
MQV Rating
4Weak
As at 08/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- Big Candle
- Consensus Expensive
- Defying Gravity
- HALO All
- HALO Balance Sheet
- HALO Price Momentum
- Near 52 Week High
- Near Resistance
- Volume Spike
Key Fundamentals
EPS 3 yr Growth
-103.10%
EBITDA Margin
6.10%
Operating Cashflow
¥136m
Free Cash Flow Return
2.30%
ROIC
0.50%
Interest Coverage
1.60
Quick Ratio
3.30
Performance
52 weeks range
Low 46.89 - 102.64
Trade Value (12mth)
US$7,795,507.00
1 week
28.72%
1 month
35.41%
YTD
58.42%
1 year
24.87%
All time high
798.00
Additional Data
Shares Outstanding (Fully Diluted)
247m
HALO Sector
Healthcare
Next Company Report Date
30-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
CNY
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Weak
Garp
Weak
Mqv Small
Neutral
Momentum
Price
Very Strong
Earnings
Weak
Growth
Earnings
Strong
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Strong
Valuation
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Tao Zhu | Individual |
| Xue Feng Yu | Individual |
| Hui Hua Mao | Individual |
| Qianxiyi Shanghai | Individual |
| Dong Xu Qiu | Individual |